National Institute of Diseases of Chest and Hospital, Dhaka, Bangladesh Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2010
NCT01580007
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

National Tuberculosis Reference Laboratory, National Institute of Diseases of Chest and Hospital (NIDCH), Dhaka, Bangladesh

Active Ingredients

Drugs in Phase 2 Trials (2)

sodium phenylbutyrate (buphenyl) (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 2)

Tuberculosis, Pulmonary (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2